Injectable Fillers for Volume Replacement in the Aging Face

Timothy M. Greco; Marcelo B. Antunes; Seth A. Yellin

doi:10.1055/s-0032-1305786

Facial Plastic Surgery, Table of Contents

Facial Plast Surg 2012; 28(01): 08-20
DOI: 10.1055/s-0032-1305786

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Injectable Fillers for Volume Replacement in the Aging Face

Timothy M. Greco

¹Division of Facial Plastics and Reconstructive Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania

²Eastern Cosmetic Surgery Institute, Bala Cynwyd, Pennsylvania

,

Marcelo B. Antunes

¹Division of Facial Plastics and Reconstructive Surgery, Department of Otorhinolaryngology–Head and Neck Surgery, University of Pennsylvania, Philadelphia, Pennsylvania

,

Seth A. Yellin

³Division of Facial Plastic Surgery, Emory Healthcare; Emory Facial Center; and Department of Otolaryngology–Head and Neck Surgery, Emory University, Atlanta, Georgia

› Author Affiliations

Abstract

In recent years, there has been a better understanding of the aging process. In addition to changes occurring in the skin envelope, significant changes occur in the subcutaneous fat and craniofacial skeleton. This has led to a paradigm shift in the therapeutic approach to facial rejuvenation. Along with soft tissue repositioning, volumizing the aging face has been found to optimize the result and achieve a more natural appearance. Early in the aging process, when there has not been a significant change to the face requiring surgical intervention, fillers alone can provide minimally invasive facial rejuvenation through volumizing. Multiple injectable soft tissue fillers and biostimulators are currently available to provide facial volume such as hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, polymethyl methacrylate, and silicone. A discussion of the morphological changes seen in the aging face, the properties of these products, and key technical concepts will be highlighted to permit optimum results when performing facial volumizing of the upper, middle, and lower thirds of the face. These fillers can act as a dress rehearsal for these patients considering structural fat grafting.

Keywords

aging face - volume loss - hyaluronic acid - calcium hydroxylapatite - poly-l-lactic acid

Full Text

References

References
1 Pessa JE. An algorithm of facial aging: verification of Lambros's theory by three-dimensional stereolithography, with reference to the pathogenesis of midfacial aging, scleral show, and the lateral suborbital trough deformity. Plast Reconstr Surg 2000; 106: 479-488 ; discussion 489–490
2 Rohrich RJ, Pessa JE. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg 2007; 119: 2219-2227 ; discussion 2228–2231
3 Rohrich RJ, Pessa JE. The retaining system of the face: histologic evaluation of the septal boundaries of the subcutaneous fat compartments. Plast Reconstr Surg 2008; 121: 1804-1809
4 Lapière CM. The ageing dermis: the main cause for the appearance of “old” skin. Br J Dermatol 1990; 122 (Suppl 35) 5-11
5 Greco TM, Elenitsas R. Localization and histological characterization of injected hyaluronic acid in excised nasolabial fold tissue. J Drugs Dermatol 2010; 9: 399-404
6 Lober CW, Fenske NA. Cutaneous aging: effect of intrinsic changes on surgical considerations. South Med J 1991; 84: 1444-1446
7 Hill WR, Montgomery H. Regional changes and changes caused by age in the normal skin. J Invest Dermatol 1940; 3: 231-245
8 Montagna W, Carlisle K. Structural changes in ageing skin. Br J Dermatol 1990; 122 (Suppl 35) 61-70
9 Bolognia JL. Dermatologic and cosmetic concerns of the older woman. Clin Geriatr Med 1993; 9: 209-229
10 Gilchrest BA. Skin aging and photoaging: an overview. J Am Acad Dermatol 1989; 21 (3 Pt 2) 610-613
11 Furnas DW. The retaining ligaments of the cheek. Plast Reconstr Surg 1989; 83: 11-16
12 Stuzin JM, Baker TJ, Gordon HL. The relationship of the superficial and deep facial fascias: relevance to rhytidectomy and aging. Plast Reconstr Surg 1992; 89: 441-449 ; discussion 450–451
13 Laurent TC. Biochemistry of hyaluronan. Acta Otolaryngol Suppl 1987; 442: 7-24
14 John HE, Price RD. Perspectives in the selection of hyaluronic acid fillers for facial wrinkles and aging skin. Patient Prefer Adherence 2009; 3: 225-230
15 Longas MO, Russell CS, He XY. Evidence for structural changes in dermatan sulfate and hyaluronic acid with aging. Carbohydr Res 1987; 159: 127-136
16 DeVore DP, Hughes E, Scott JB. Effectiveness of injectable filler materials for smoothing wrinkle lines and depressed scars. Med Prog Technol 1994; 20: 243-250
17 Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther 2008; 10: 35-42
18 Restylane^® (Package Insert). Scottsdale, AZ: Medicis Aesthetics Holdings, Inc.; 2010
19 JuveDerm^® Ultra (package insert). Paris, France: Corneal; 2010
20 JuveDerm^® Ultra Plus (package insert). Paris, France: Corneal; 2010
21 Perlane^® (Package Insert). Scottsdale, AZ: Medicis Aesthetics Holdings, Inc.; 2010
22 Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg 2003; 29: 802-809
23 Rohrich RJ, Ghavami A, Crosby MA. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg 2007; 120: 41-54
24 Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002; 28: 491-494
25 Fernández-Aceñero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 2003; 29: 1225-1226
26 Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 2004; 114: 277
27 Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther 2004; 6: 223-226
28 LeGeros RZ. Biodegradation and bioresorption of calcium phosphate ceramics. Clin Mater 1993; 14: 65-88
29 Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthetic Plast Surg 2003; 27: 354-366 ; discussion 367
30 Misiek DJ, Kent JN, Carr RF. Soft tissue responses to hydroxylapatite particles of different shapes. J Oral Maxillofac Surg 1984; 42: 150-160
31 Moers-Carpi MM, Tufet JO. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial. Dermatol Surg 2008; 34: 210-215
32 Moers-Carpi M, Vogt S, Santos BM, Planas J, Vallve SR, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg 2007; 33 (Suppl 2) S144-S151
33 Felderman LI. RadiesseTM for facial rejuvenation. Cosmetic Dermatol 2005; 18: 823-826
34 Jacovella PF, Peiretti CB, Cunille D, Salzamendi M, Schechtel SA. Long-lasting results with hydroxylapatite (Radiesse) facial filler. Plast Reconstr Surg 2006; 118 (3, Suppl) 15S-21S
35 Radiance FP. Facial Plast Surg 2004; 20: 165-169
36 Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-1148
37 Sculptra^® (Package Insert). Bridgewater, NJ: Sanofi-Aventis U.S., LLC; 2010
38 Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med 2006; 7: 181-185
39 Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118 (3, Suppl) 55S-63S
40 Lowe NJ. Optimizing poly-L-lactic acid use. J Cosmet Laser Ther 2008; 10: 43-46
41 Lacombe V. Sculptra: a stimulatory filler. Facial Plast Surg 2009; 25: 95-99
42 Mest DR, Humble GM. Duration of correction for human immunodeficiency virus-associated lipoatrophy after retreatment with injectable poly-L-lactic acid. Aesthetic Plast Surg 2009; 33: 654-656
43 Lowe NJ. Optimizing poly-L-lactic acid use. J Cosmet Laser Ther 2008; 10: 43-46
44 Borelli C, Kunte C, Weisenseel P, Thoma-Greber E, Korting HC, Konz B. Deep subcutaneous application of poly-L-lactic acid as a filler for facial lipoatrophy in HIV-infected patients. Skin Pharmacol Physiol 2005; 18: 273-278
45 Haneke E. Polymethyl methacrylate microspheres in collagen. Semin Cutan Med Surg 2004; 23: 227-232
46 Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29: 573-587 ; discussion 587
47 Hilinski JM, Cohen SR. Soft tissue augmentation with ArteFill. Facial Plast Surg 2009; 25: 114-119
48 Hoffmann C, Schuller-Petrovic S, Soyer HP, Kerl H. Adverse reactions after cosmetic lip augmentation with permanent biologically inert implant materials. J Am Acad Dermatol 1999; 40: 100-102
49 Rudolph CM, Soyer HP, Schuller-Petrovic S, Kerl H. Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol 1999; 23: 113-117
50 Jones DH, Carruthers A, Orentreich D , et al. Highly purified 1000-cSt silicone oil for treatment of human immunodeficiency virus-associated facial lipoatrophy: an open pilot trial. Dermatol Surg 2004; 30: 1279-1286
51 Chasan PE. The history of injectable silicone fluids for soft-tissue augmentation. Plast Reconstr Surg 2007; 120: 2034-2040 ; discussion 2041–2043
52 Narins RS, Beer K. Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential. Plast Reconstr Surg 2006; 118 (3, Suppl) 77S-84S
53 Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg 2006; 118 (3, Suppl) 108S-120S
54 Pessa JE, Zadoo VP, Yuan C , et al. Concertina effect and facial aging: nonlinear aspects of youthfulness and skeletal remodeling, and why, perhaps, infants have jowls. Plast Reconstr Surg 1999; 103: 635-644
55 Shaw Jr RB, Kahn DM. Aging of the midface bony elements: a three-dimensional computed tomographic study. Plast Reconstr Surg 2007; 119: 675-681 ; discussion 682–683
56 Niamtu III J. Accurate and anatomic midface filler injection by using cheek implants as an injection template. Dermatol Surg 2008; 34: 93-95 ; discussion 96
57 Levy PM. The “Nefertiti lift”: a new technique for specific re-contouring of the jawline. J Cosmet Laser Ther 2007; 9: 249-252